WATERTOWN, Mass.–(BUSINESS WIRE)–Lyndra Therapeutics, a clinical-stage biotechnology company working to make daily pills a thing of the past with the first-ever ultra-long-acting, sustained release oral therapies, today announced that members of its management team will participate in the SVB Leerink 10th Annual Global Healthcare Conference being held virtually February 22-26, 2021. About Lyndra Therapeutics Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained r